Theraclion Tries Keytruda-HiFU Combo To Treat Metastatic Breast Cancer
Executive Summary
US FDA has approved the University of Virgina's plan to evaluate a therapy combining Theraclion's high intensity focused ultrasound with Merck's Keytruda (pembrolizumab) immunotherapy drug for the treatment of metastatic breast cancer.